Annette C. Reboli
- Infectious Diseases top 0.05%
- Antifungal resistance and susceptibility 33
- Antimicrobial Resistance in Staphylococcus 5
- Parasitic Diseases Research and Treatment 4
- Epidemiology top 0.1%
- Fungal Infections and Studies 26
- Pneumocystis jirovecii pneumonia detection and treatment 8
- Nail Diseases and Treatments 7
- Clinical Biochemistry top 0.5%
- Bacterial Identification and Susceptibility Testing 5
- Microbiology top 0.5%
-
- Innovations in Medical Education 4
Annette C. Reboli
60 papers receiving 10.2k citations
Hit Papers
Peers
Comparison fields: 5 of 141
- Infectious Diseases 8.6k
- Applied Microbiology and Biotechnology 862
- Epidemiology 6.6k
- Clinical Biochemistry 734
- Microbiology 507
Countries citing papers authored by Annette C. Reboli
This map shows the geographic impact of Annette C. Reboli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annette C. Reboli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annette C. Reboli more than expected).
Fields of papers citing papers by Annette C. Reboli
This network shows the impact of papers produced by Annette C. Reboli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annette C. Reboli. The network helps show where Annette C. Reboli may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Annette C. Reboli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 6 | |
| 2 | Epidemiology and Outcomes of Invasive Candidiasis Due to Non-albicans Species of Candida in 2,496 Patients: Data from the Prospective Antifungal Therapy (PATH) Registry 2004–2008breakdown → | 2014 | 321 |
| 3 | 2013 | 20 | |
| 4 | Impact of Treatment Strategy on Outcomes in Patients with Candidemia and Other Forms of Invasive Candidiasis: A Patient-Level Quantitative Review of Randomized Trialsbreakdown → | 2012 | 587 |
| 5 | 2012 | 48 | |
| 6 | 2011 | 78 | |
| 7 | 2011 | 13 | |
| 8 | 2011 | 72 | |
| 9 | Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of Americabreakdown → | 2009 | 2325 |
| 10 | 2008 | 24 | |
| 11 | Anidulafungin versus Fluconazole for Invasive Candidiasisbreakdown → | 2007 | 618 |
| 12 | 2007 | 24 | |
| 13 | 2005 | 22 | |
| 14 | 1999 | 97 | |
| 15 | Itraconazole (IT) compared with amphotericin B (AMB) as empirical therapy for persistent fever of unknown origin (FUO) in neutropenic patients (PTS) | 1999 | 9 |
| 16 | 1999 | 25 | |
| 17 | 1998 | 461 | |
| 18 | 1997 | 4 | |
| 19 | 1996 | 37 | |
| 20 | 1996 | 59 |
About Annette C. Reboli
Annette C. Reboli is a scholar working on Infectious Diseases, Epidemiology and Applied Microbiology and Biotechnology, having authored 61 papers that have together received 10.5k indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (33 papers), Fungal Infections and Studies (26 papers), Pneumocystis jirovecii pneumonia detection and treatment (8 papers), Nail Diseases and Treatments (7 papers), Antimicrobial Resistance in Staphylococcus (5 papers), Bacterial Identification and Susceptibility Testing (5 papers), Parasitic Diseases Research and Treatment (4 papers) and Innovations in Medical Education (4 papers). The work is most often cited by research in Infectious Diseases (8.6k citations), Applied Microbiology and Biotechnology (862 citations) and Epidemiology (6.6k citations). Annette C. Reboli has collaborated with scholars based in United States, Canada and Netherlands. Frequent co-authors include Peter G. Pappas, Thomas J. Walsh, David R. Andes, Luis Ostrosky‐Zeichner, Carol A. Kauffman, José A. Vázquez, Cornelius J. Clancy, Mindy G. Schuster, Jack D. Sobel and Kieren A. Marr.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.